FEATURE: In a world scrambling for sustainable solutions to feed a growing population and fight climate change, one Indian scientist-turned-entrepreneur is betting on something small, winged, and surprisingly powerful—the Black Soldier Fly. Meet Dr. Jayashankar Das, a deep-tech visionary from Odisha who is transforming how the world thinks about protein, antibiotics, and agricultural waste. His company, Elmentoz Research, isn’t just disrupting the animal nutrition industry—it’s redefining it from the ground up, using insects to build a cleaner, healthier food system.
What makes his journey remarkable isn’t just the innovation, but the conviction behind it. Raised in a modest family in Cuttack, Dr. Das didn’t inherit a biotech empire—he built one from scratch, fueled by academic brilliance, government service, and a desire to solve real-world problems. From decoding viral genomes during the COVID-19 crisis to pioneering smart proteins that could replace antibiotic-laced feed in livestock and aquaculture, Dr. Das has become a symbol of what’s possible when science steps out of the lab and into the fields, farms, and ecosystems that need it most.
His early career was steeped in academic excellence. A gold medalist in his Master’s program, Dr. Das joined the Ministry of Science & Technology, taking up research assignments in India’s Northeast. He worked across institutions in Shillong and Sikkim, where the interface between environmental conservation and biotechnology first began to shape his thinking. Later, in Gujarat, he played an instrumental role in building science policy, biotech infrastructure, and startup ecosystems as part of the state’s biotechnology mission. These roles gave him a 360-degree understanding of how science, government, and industry could work together to create impact—but also revealed a gap. Innovation wasn’t reaching the ground.
That gap became a mission. During the COVID-19 pandemic, Dr. Das returned to Odisha, where he played a critical role in public health initiatives, including leading India’s first COVID genome sequencing efforts. But even then, his focus remained rooted in a long-standing crisis he had tracked for years: the rise of antimicrobial resistance (AMR). He was struck by a statistic—over 70% of the world’s antibiotics are not consumed by humans but by animals, embedded in their feed. This overuse leads to antibiotic-resistant bacteria, threatening both food safety and global health.

Determined to find an indigenous, sustainable solution, he founded Elmentoz Research in Bhubaneswar. The company’s approach is deceptively simple but profoundly impactful: use Black Soldier Fly (BSF) larvae, raised on organic waste, to produce protein-rich animal feed that replaces conventional soy and fish meal. This feed, known as ELGROW, contains 45–60% protein and is rich in essential oils and nutrients. But the real breakthrough lies in their proprietary antimicrobial peptides, branded as ELTIDE, which target animal immunity and disease resistance—effectively replacing the need for antibiotics in livestock and aquaculture.
What Elmentoz offers isn’t just animal feed—it’s a precision animal health and nutrition solution. ELTIDE peptides are custom-designed for species such as broiler poultry, tilapia, shrimp, and even pets. Early trials in Odisha showed staggering results: poultry fed with ELGROW-based diets experienced zero mortality, healthier growth, and meat with no cholesterol or antibiotic residues. For farmers, this means lower feed costs, higher yield quality, and access to antibiotic-free premium markets.
Dr. Das didn’t stop at feed. Under the ELGROW brand, Elmentoz also produces nutrient-dense oils, while their ELFRASH line converts BSF residue into high-value, chitin-enriched organic fertilizer. Every product is designed to feed into the next, creating a zero-waste, circular economy model where waste becomes input and output becomes value. According to Dr. Das, this model is not only good science—it’s good economics and even better environmental stewardship.
Taking this mission to the next level, Elmentoz is now setting up what will be India’s largest smart protein GMP-certified manufacturing facility, slated for commissioning in October 2025. Designed to serve the growing demand for precision animal nutrition in the poultry and aquaculture sectors, the plant will process over 2,000 metric tons of input waste each month. Scaling from a single idea to a facility of this magnitude highlights not only Dr. Das’s scientific vision but also his strong belief in India’s potential to lead in deep-tech innovation.
Building a biotech startup in India’s relatively nascent deep-tech market wasn’t easy. It took over three years of intense R&D, merging disciplines like molecular biology, AI, and bioinformatics, to bring Elmentoz’s vision to life. The challenge wasn’t just scientific—it was cultural. Deep-tech ventures often face resistance from conventional markets focused on short-term gains. But Dr. Das’s persistence, combined with growing global awareness around AMR and clean protein, is turning the tide.
From its base at Bhubaneswar’s DLF campus, Elmentoz is expanding fast. With manufacturing plants in both Bhubaneswar and Hyderabad, the company has established export partnerships in the UK and Norway, particularly with the salmon farming industry. They’re part of the Cambridge Cleantech cohort and operate an R&D wing in the UK, allowing them to blend global research capabilities with indigenous solutions.
Dr. Das envisions a bold future. Within the next three to five years, Elmentoz aims to become Asia’s largest smart protein manufacturer. Plans include a 100-ton manufacturing facility that alone could eliminate over 100,000 metric tons of CO₂ emissions annually. Even more ambitious is a nationwide hub-and-spoke model that will train and empower farmers to raise BSF on-site, with Elmentoz buying back the larvae to feed into its production cycle. Over five years, they hope to remove 5 lakh metric tons of CO₂ and 10,000 tons of antibiotics from the food chain—contributing meaningfully to India’s climate and health goals.
For him, the story isn’t just about protein. It’s about resilience—of nature, of science, and of individuals who dare to challenge the status quo. His message to young Indian entrepreneurs is a call to action.
“I believe India is going to be the next big innovation hub,” he says. “But what we need is more scientific courage—more people who fail and bounce back, who don’t fear rejection or complexity. The journey won’t be easy, especially in deep tech or biotech, but it’s worth it. Solve a real problem. Focus on value innovation, not just valuation. And most importantly, don’t wait to be perfect—just start, learn, pivot, and scale.”
In a country teeming with potential but often constrained by legacy thinking, Dr. Jayashankar Das is proving that real innovation doesn’t just come from ideas—it comes from the will to act on them. With Elmentoz, he is turning insects into instruments of global change. And in doing so, he’s not just feeding the world—he’s healing it.